KEMIFARMA Consulting ApS: Financial statements 2012
CVR: 34709955
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
KEMIFARMA Consulting ApS (CVR 34709955) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -7,500 and a net result of DKK 449,076. Equity in the 2012 report amounted to DKK 1,813,612. The solvency ratio was 99.6%.
- Gross Profit
- DKK -7,500
- Profit/Loss
- DKK 449,076
- Equity
- DKK 1,813,612
- Total Assets
- DKK 1,821,112
Official annual report
Keep an eye on KEMIFARMA Consulting ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of July 11, 2012, ANKJÆR-JENSEN, STATSAUTORISEREDE REVISORER A/S has been appointed auditor of KEMIFARMA Consulting ApS.
As of July 11, 2012, Christian Hede-Andersen is registered as director of KEMIFARMA Consulting ApS.
As of July 11, 2012, Christian Hede-Andersen is registered as an owner of KEMIFARMA Consulting ApS with an ownership share of 100%.
KEMIFARMA Consulting ApS was founded on July 11, 2012.
About KEMIFARMA Consulting ApS
KEMIFARMA Consulting ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named KEMIFARMA HOLDING ApS. The management consists of Christian Hede-Andersen. The company is owned by Christian Hede-Andersen. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -57,469 and a net result of DKK 541,385 compared with DKK -378,700 the year before. Equity in the 2025 report amounted to DKK 3,414,022.